On Friday, Shares of CNO Financial Group Inc (NYSE:CNO), climbed 2.77% to $19.30.
CNO Financial Group Inc, received 2020 Women on Board’s highest honor – a Winning (W) rating – for the gender diversity of its board of directors. Two of the nine (22 percent) directors on CNO Financial Group’s board are women.
Ellyn Brown joined CNO Financial Group’s board of directors in May 2012. Ms. Brown has served on a number of other boards of public and not-for-profit entities, counting NYSE-Euronext (the owner of the New York Stock Exchange, preceding to its acquisition by ICE), the Financial Industry Regulatory Authority (FINRA), and the Financial Accounting Foundation (parent of FASB and GASB), and formerly chaired the board of NYSE Regulation, Inc. Preceding to her retirement from an active law and consulting practice, she offered legal, operations, regulatory and governance advice to financial services industry clients and other enterprises operating in heavily-regulated, high-scrutiny environments, and worked with companies undertaking noteworthy transformations.
CNO Financial Group, Inc., through its auxiliaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States.
Shares of MedAssets, Inc. (NASDAQ:MDAS), dipped -0.68% to $22.02.
MedAssets, declared that Jackson Health System (Jackson), a not-for-profit academic medical system serving residents of Miami-Dade County, renewed its supply chain relationship with the company to achieve greater cost reduction across the organization. Plans call for Jackson to continue use of MedAssets Spend and Pharmacy Analytics, which assist health systems monitor and control pharmacy and med/surg supply costs and improve contract negotiations through advanced analytics. The system also will continue to gain access to industry-leading pricing on supplies with the company’s national group purchasing organization.
The renewal builds upon savings of more than $42 million since 2010 by leveraging MedAssets supply chain solutions in addition to its recently accomplished enterprise consulting engagement, which focused on utilizing data-driven insights, evidence-based technologies and consulting expertise for sustainable margin improvement.
MedAssets, a performance improvement company, provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers, and other service providers and product manufacturers in the United States.
Shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO), during its Friday’s trading session fell -0.50% to $28.00.
Take-Two Interactive Software, declared that one new Monster and four new Hunters are coming to Evolve, the 4v1 shooter in which four Hunters cooperatively fight to take down a single-player controlled Monster. Offered individually, or as part of Hunting Season 2, all five new characters will be made accessible preceding to the end of Take-Two Interactive, Inc.’s fiscal year on March 31, 2016. The first new character, Lennox (Assault class), will be accessible on June 23, 2015.
Take-Two Interactive Software, develops, publishes, and markets interactive entertainment for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels.
Finally, Esperion Therapeutics Inc (NASDAQ:ESPR), gained 1.23% Friday.
Esperion Therapeutics Inc, declared president and chief executive officer, Tim M. Mayleben, will present at the JMP Securities Life Science Conference in New York City on Tuesday, June 23, 2015 at 4:30 P.M. Eastern Time.
Esperion Therapeutics, a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
